The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Affiliation
University of Connecticut
Country
United States of America
1. Current Status, Position
As of 2003, Prof Dr Coleman (PharmD) has held a full-time faculty position at the University of Connecticut, USA. He was granted tenure in 2009 and promoted to full Professor in 2013. He currently serves as the Co-Director and Methods-Chief for UConn’s Agency for Healthcare and Research Quality Evidence-Based Practice Center.
2. Education
Prof Dr Craig Coleman earned his Bachelor’s degree from Clark University in Worcester in Massachusetts, USA and his Doctor of Pharmacy degree from the University of Connecticut School of Pharmacy in Storrs, Connecticut, USA. He then completed a 2-year outcomes research fellowship at Hartford Hospital, where he specialized in health economics and outcomes research (HEOR).
3. Research Area
Prof Dr Coleman has authored more than 200 publications in peer-reviewed journals, including JAMA, Annals of Internal Medecine, Circulation, CHEST, Journal of Thrombosis and Haemostatsis, Thrombosis and Haemostatsis, Thrombosis Research, and The Lancet.
4. Conflict of interest: Prof Dr Coleman is currently:
- a speaker and consultant for Bayer Pharma AG, and also receives research grants from Bayer Pharma AG
- a speaker and consultant for Janssen Scientific Affairs, and also receives research grants from Janssen Scientific Affairs
- a consultant and member of the Advisory Board for Portola Pharmaceuticals
- a consultant for Boehringer-Ingeleheim
- receiving research grants from Pfizer